↓ Skip to main content

Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib

Overview of attention for article published in OncoTargets and therapy, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
facebook
1 Facebook page

Readers on

mendeley
20 Mendeley
Title
Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib
Published in
OncoTargets and therapy, February 2019
DOI 10.2147/ott.s188296
Pubmed ID
Authors

Shun Lu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 25%
Student > Bachelor 4 20%
Researcher 3 15%
Unspecified 1 5%
Student > Doctoral Student 1 5%
Other 1 5%
Unknown 5 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 20%
Pharmacology, Toxicology and Pharmaceutical Science 2 10%
Unspecified 1 5%
Mathematics 1 5%
Business, Management and Accounting 1 5%
Other 4 20%
Unknown 7 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2019.
All research outputs
#4,319,941
of 25,728,855 outputs
Outputs from OncoTargets and therapy
#167
of 3,013 outputs
Outputs of similar age
#92,182
of 449,873 outputs
Outputs of similar age from OncoTargets and therapy
#8
of 84 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,873 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.